82 related articles for article (PubMed ID: 37438683)
1. Pre-chemoradiotherapy high platelet counts predict jaw osteoradionecrosis in locally advanced nasopharyngeal carcinoma patients.
Somay E; Topkan E; Kucuk A; Ozturk D; Ozkan EE; Ozdemir BS; Besen AA; Mertsoylu H; Pehlivan B; Selek U
J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101838. PubMed ID: 38518893
[TBL] [Abstract][Full Text] [Related]
2. Low hemoglobin levels predict increased radiation-induced trismus rates in nasopharyngeal cancer.
Somay E; Yilmaz B; Topkan E; Pehlivan B; Selek U
Oral Dis; 2024 Apr; 30(3):1052-1060. PubMed ID: 37154238
[TBL] [Abstract][Full Text] [Related]
3. International Expert-Based Consensus Definition, Staging Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Inter-Disciplinary Modified Delphi Study.
International ORAL Consortium
medRxiv; 2024 Apr; ():. PubMed ID: 38645105
[TBL] [Abstract][Full Text] [Related]
4. Comment on Prospective Study to Compare Efficacy of Conventional Chemoradiotherapy with Hypofractionated Chemoradiotherapy in Locally Advanced Carcinoma of Oropharynx.
Topkan E; Somay E; Selek U
Asian Pac J Cancer Prev; 2024 Feb; 25(2):367-368. PubMed ID: 38415519
[No Abstract] [Full Text] [Related]
5. Disruptor: Computational identification of oncogenic mutants disrupting protein-protein and protein-DNA interactions.
Kugler V; Lieb A; Guerin N; Donald BR; Stefan E; Kaserer T
Commun Biol; 2023 Jul; 6(1):720. PubMed ID: 37443295
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapy.
Alam SSM; Samanta A; Uddin F; Ali S; Hoque M
Pharmacol Rep; 2023 Aug; 75(4):907-922. PubMed ID: 37440106
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of miR-17-5p may negatively impact p300/CBP factor-associated inflammation in a hypercholesterolemic advanced prostate cancer model.
Pimenta R; Camargo JA; Gonçalves GL; Ghazarian V; Candido P; Guimarães VR; Romão P; Chiovatto C; da Silva KS; Dos Santos GA; Silva IA; Nahas WC; Leite KR; Pessoa AFM; Viana NI; Reis ST
Mol Biol Rep; 2023 Sep; 50(9):7333-7345. PubMed ID: 37439896
[TBL] [Abstract][Full Text] [Related]
8. Exploring the landscape of oral cancer care: real-world scenario.
Thaduri A; Ahuja R; Kaul P; Malhotra M; Garg PK
Eur Arch Otorhinolaryngol; 2023 Nov; 280(11):5151-5152. PubMed ID: 37658877
[No Abstract] [Full Text] [Related]
9. Letter to the Editor regarding "Long‑term swallow outcomes and factors affecting swallowing dysfunction and quality of life among oral cancer patients: a prospective observational study" by Thaduri et al. Eur Arch Otorhinolaryngol. 2023 Aug 7. doi: 10.1007/s00405-023-08155-x.
Topkan E; Somay E; Selek U
Eur Arch Otorhinolaryngol; 2023 Nov; 280(11):5149-5150. PubMed ID: 37594546
[No Abstract] [Full Text] [Related]
10. Radiation-induced temporo-mandibular joint disorder in post-radiotherapy nasopharyngeal carcinoma patients: assessment and treatment.
Wu VW; Lam YN
J Med Radiat Sci; 2016 Jun; 63(2):124-32. PubMed ID: 27350892
[TBL] [Abstract][Full Text] [Related]
11. Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management.
Kün-Darbois JD; Fauvel F
Morphologie; 2021 Jun; 105(349):170-187. PubMed ID: 33281055
[TBL] [Abstract][Full Text] [Related]
12. Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients.
Topkan E; Somay E; Yilmaz B; Pehlivan B; Selek U
BMC Cancer; 2023 Jul; 23(1):651. PubMed ID: 37438683
[TBL] [Abstract][Full Text] [Related]
13. Worth of pan-immune-inflammation value in trismus prediction after concurrent chemoradiotherapy for nasopharyngeal carcinomas.
Somay E; Yilmaz B; Topkan E; Ozdemir BS; Ozturk D; Besen AA; Mertsoylu H; Selek U
Int J Biol Markers; 2024 Mar; 39(1):80-88. PubMed ID: 38192114
[TBL] [Abstract][Full Text] [Related]
14. The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients.
Somay E; Topkan E; Pehlivan UA; Yilmaz B; Besen AA; Mertsoylu H; Pehlivan B; Selek U
Tomography; 2024 Jan; 10(1):79-89. PubMed ID: 38250953
[TBL] [Abstract][Full Text] [Related]
15. Hemoglobin-to-platelet ratio in predicting the incidence of trismus after concurrent chemoradiotherapy.
Somay E; Yilmaz B; Topkan E; Kucuk A; Haksoyler V; Pehlivan B; Selek U; Araz K
Oral Dis; 2023 Oct; 29(7):2962-2970. PubMed ID: 36038508
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
